Cronos Group Inc
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Michael Ryan Gorenstein
- Full Time Employees
- 610
- Sector
- Health technology
- Industry
- Pharmaceuticals: other
- Address
- 4491 Concession Road 12 Stayner ON Canada L0M 1S0
- IPO Date
- May 7, 2014
- Website
- thecronosgroup.com
- Similar Companies
- Business
- Cronos Group Inc. functions as an advanced global cannabinoid enterprise. It is engaged in the creation, marketing, and movement of hemp-derived wellness and beauty items, distributed across e-commerce platforms, retail outlets, and hospitality alliances, primarily under the Lord Jones and Happy Dance labels in the United States. The company also focuses on the cultivation, manufacturing, and commercialization of cannabis and various cannabis derivatives for both medical and adult-use sectors. It offers a diverse portfolio including dried flower, pre-rolls, edibles, vapes, and extracts through wholesale and direct-to-consumer channels. Its brand lineup includes PEACE NATURALS, serving as a global wellness platform for medical cannabis, and adult-use brands such as Spinach, known for its innovative products like Spinach FEELZ which incorporates cultured rare cannabinoids, and COVE. Cronos Group also maintains an international presence, exporting its cannabis and cannabis oils to markets including Germany, Israel, Australia, Switzerland, and the UK. Established in 2012, the company is headquartered in Toronto, Canada.
Company News
Cronos Completes Acquisition of CanAdelaar, Europe's Largest Adult-Use Cannabis Company
Fan-Favorite and Limited-Edition Spinach® Green Apple-Flavored Products are Returning for the Fall Season
CRON Stock Rises 17% in Three Months: Time to Buy the Dip or Cash Out?
Cronos Group Inc. to Hold 2026 Third Quarter Earnings Conference Call on November 5, 2026
Financial Survey: Eton Pharmaceuticals (NASDAQ:ETON) vs. Cronos Group (NASDAQ:CRON)
Cronos Group Inc. $CRON Shares Newly Acquired by Bank of America Corp DE
Cronos Group Inc. (CRON:CA) Analyst/Investor Day Transcript
Cronos Group Investor Day Highlights Cannabis Growth, Cash Flow and Global Ambitions
Cronos Hosts 2026 Investor Day
Head to Head Contrast: Lyra Therapeutics (OTCMKTS:LYRA) versus Cronos Group (NASDAQ:CRON)
Cronos: Invest In Cannabis With 50% Net Cash And GAAP Profitability
Cronos to Host 2026 Investor Day at its Cronos GrowCo Facility in Kingsville, Ontario
Are Medical Stocks Lagging Cronos Group (CRON) This Year?
Cronos' brand Spinach® Expands its Best-Selling Lineups of Edibles and Vapes
4 Healthcare Stocks to Safeguard Your Portfolio as Fed Plans Rate Hike
Surging Earnings Estimates Signal Upside for Cronos (CRON) Stock
Marijuana reform is emerging as a midterm elections issue on both sides of the aisle
Cronos Group: This Cannabis Name Isn't Reliant On U.S. Legalization Efforts
Cronos: Strong Quarter, And The Outlook For The Future Is Positive Thanks To M&A
Cronos Group Inc. (CRON:CA) Q2 2026 Earnings Call Transcript